Skip to main content
Erschienen in: Inflammation 5/2018

23.07.2018 | ORIGINAL ARTICLE

Changes of Treg/Th17 Ratio in Spleen of Acute Gouty Arthritis Rat Induced by MSU Crystals

verfasst von: Xiao-Juan Dai, Jin-Hui Tao, Xuan Fang, Yuan Xia, Xiao-Mei Li, Yi-Ping Wang, Xiang-Pei Li

Erschienen in: Inflammation | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Acute gouty arthritis is the inflammation of joint tissues in the acute form due to the deposition of monosodium urate (MSU) crystals. Regulatory T cells (Tregs) and Th17 cells play an important role in the development and progression of inflammatory diseases. However, the expression and role of Tregs and Th17 cells are not clear in this disease. Here, we investigated the changes of Tregs, Th17 cells, and Treg/Th17 ratio in spleen, as well as the inflammatory cytokines in blood and joint tissue pathology in acute gouty arthritis rat induced by MSU. We found that both the percentages of Tregs and Th17 cells in spleen increased at an early stage (6 h). Tregs decreased at 12 and 24 h, and rise again at 48 and 72 h. However, Th17 cells reached its peak at 24 h, and then decreased after 48 h. Treg/Th17 ratio showed an initial decrease and then increase, and further reached its minimum value at 24 h. But the ratios of Treg/Th17at all times were lower than that of normal control. The level of serum cytokines (IL-1β, IL-6, IL-17, TNF-α, and IL-10) showed an opposite trend to Treg/Th17 ratio, except the level of TGF-β1 was similar to Tregs. In summary, Tregs and Th17 cells in spleen changed over time during the development of acute gouty arthritis. Decrease of Treg/Th17 ratio was consistent with inflammation development in the joints, suggesting that Treg/Th17 imbalance may involve in pathogenesis of acute gouty arthritis.
Literatur
1.
Zurück zum Zitat Murunikkara, V., and M. Rasool. 2014. Trikatu, a herbal compound that suppresses monosodium urate crystal-induced inflammation in rats, an experimental model for acute gouty arthritis. Cell Biochemistry & Function 32 (1): 106–114.CrossRef Murunikkara, V., and M. Rasool. 2014. Trikatu, a herbal compound that suppresses monosodium urate crystal-induced inflammation in rats, an experimental model for acute gouty arthritis. Cell Biochemistry & Function 32 (1): 106–114.CrossRef
2.
Zurück zum Zitat Schlesinger, N., and R.G. Thiele. 2010. The pathogenesis of bone erosions in gouty arthritis. Annals of the Rheumatic Diseases 69 (11): 1907–1912.CrossRefPubMed Schlesinger, N., and R.G. Thiele. 2010. The pathogenesis of bone erosions in gouty arthritis. Annals of the Rheumatic Diseases 69 (11): 1907–1912.CrossRefPubMed
3.
Zurück zum Zitat Sakaguchi, S., M. Miyara, C.M. Costantino, and D.A. Hafler. 2010. Foxp3+ regulatory T cells in the human immune system. Nature Reviews Immunology 10 (7): 490–500.CrossRefPubMed Sakaguchi, S., M. Miyara, C.M. Costantino, and D.A. Hafler. 2010. Foxp3+ regulatory T cells in the human immune system. Nature Reviews Immunology 10 (7): 490–500.CrossRefPubMed
4.
Zurück zum Zitat Piccirillo, C.A., E. D’Hennezel, E. Sgouroudis, and E. Yurchenko. 2008. Cd4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas. Current Opinion in Immunology 20 (6): 655–662.CrossRefPubMed Piccirillo, C.A., E. D’Hennezel, E. Sgouroudis, and E. Yurchenko. 2008. Cd4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas. Current Opinion in Immunology 20 (6): 655–662.CrossRefPubMed
6.
Zurück zum Zitat Zhou, L., J.E. Lopes, M.M. Chong, I.I. Ivanov, R. Min, G.D. Victora, et al. 2008. TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function. Nature 453: 236–240.CrossRefPubMedPubMedCentral Zhou, L., J.E. Lopes, M.M. Chong, I.I. Ivanov, R. Min, G.D. Victora, et al. 2008. TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function. Nature 453: 236–240.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Coderre, T.J., and P.D. Wall. 1987. Ankle joint urate arthritis (AJUA) in rats: an alternative animal model of arthritis to that produced by Freund’s adjuvant. Pain 28 (3): 379–393.CrossRefPubMed Coderre, T.J., and P.D. Wall. 1987. Ankle joint urate arthritis (AJUA) in rats: an alternative animal model of arthritis to that produced by Freund’s adjuvant. Pain 28 (3): 379–393.CrossRefPubMed
8.
Zurück zum Zitat Park, J.S., Y. Oh, O. Park, C.A. Foss, S.M. Lim, D.G. Jo, et al. 2017. Pegylated trail ameliorates experimental inflammatory arthritis by regulation of Th17 cells and regulatory T cells. Journal of Controlled Release 267: 163–171.CrossRefPubMed Park, J.S., Y. Oh, O. Park, C.A. Foss, S.M. Lim, D.G. Jo, et al. 2017. Pegylated trail ameliorates experimental inflammatory arthritis by regulation of Th17 cells and regulatory T cells. Journal of Controlled Release 267: 163–171.CrossRefPubMed
9.
Zurück zum Zitat Hartmann, P., A. Szabó, G. Eros, D. Gurabi, G. Horváth, I. Németh, et al. 2009. Anti-inflammatory effects of phosphatidylcholine in neutrophil leukocyte-dependent acute arthritis in rats. European Journal of Pharmacology 622 (1–3): 58–64.CrossRefPubMed Hartmann, P., A. Szabó, G. Eros, D. Gurabi, G. Horváth, I. Németh, et al. 2009. Anti-inflammatory effects of phosphatidylcholine in neutrophil leukocyte-dependent acute arthritis in rats. European Journal of Pharmacology 622 (1–3): 58–64.CrossRefPubMed
10.
Zurück zum Zitat Fasching, P., M. Stradner, W. Graninger, C. Dejaco, and J. Fessler. 2017. Therapeutic potential of targeting the Th17/Treg axis in autoimmune disorders. Molecules 22 (1): 134.CrossRef Fasching, P., M. Stradner, W. Graninger, C. Dejaco, and J. Fessler. 2017. Therapeutic potential of targeting the Th17/Treg axis in autoimmune disorders. Molecules 22 (1): 134.CrossRef
11.
Zurück zum Zitat An, N., Y. Chen, C. Wang, C. Yang, Z.H. Wu, J. Xue, et al. 2017. Chloroquine autophagic inhibition rebalances Th17/Treg-mediated immunity and ameliorates systemic lupus erythematosus. Cellular Physiology & Biochemistry 44 (1): 412–422.CrossRef An, N., Y. Chen, C. Wang, C. Yang, Z.H. Wu, J. Xue, et al. 2017. Chloroquine autophagic inhibition rebalances Th17/Treg-mediated immunity and ameliorates systemic lupus erythematosus. Cellular Physiology & Biochemistry 44 (1): 412–422.CrossRef
12.
Zurück zum Zitat Pesce, B., L. Soto, F. Sabugo, P. Wurmann, M. Cuchacovich, M.N. López, et al. 2013. Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients. Clinical & Experimental Immunology 171 (3): 237–242.CrossRef Pesce, B., L. Soto, F. Sabugo, P. Wurmann, M. Cuchacovich, M.N. López, et al. 2013. Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients. Clinical & Experimental Immunology 171 (3): 237–242.CrossRef
13.
Zurück zum Zitat Tramontini, N., C. Huber, L.B. Ru, R.A. Terkeltaub, and K.S. Kilgore. 2004. Central role of complement membrane attack complex in monosodium urate crystal–induced neutrophilic rabbit knee synovitis. Arthritis & Rheumatology 50 (8): 2633–2639.CrossRef Tramontini, N., C. Huber, L.B. Ru, R.A. Terkeltaub, and K.S. Kilgore. 2004. Central role of complement membrane attack complex in monosodium urate crystal–induced neutrophilic rabbit knee synovitis. Arthritis & Rheumatology 50 (8): 2633–2639.CrossRef
14.
Zurück zum Zitat Taylor, W.J., J. Fransen, T.L. Jansen, N. Dalbeth, H.R. Schumacher, M. Brown, et al. 2015. Study for updated gout classification criteria: identification of features to classify gout. Arthritis Care & Research 67 (9): 1304–1315.CrossRef Taylor, W.J., J. Fransen, T.L. Jansen, N. Dalbeth, H.R. Schumacher, M. Brown, et al. 2015. Study for updated gout classification criteria: identification of features to classify gout. Arthritis Care & Research 67 (9): 1304–1315.CrossRef
15.
Zurück zum Zitat Nistala, K., H. Moncrieffe, K.R. Newton, H. Varsani, P. Hunter, and L.R. Wedderburn. 2008. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis & Rheumatology 58 (3): 875–887.CrossRef Nistala, K., H. Moncrieffe, K.R. Newton, H. Varsani, P. Hunter, and L.R. Wedderburn. 2008. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis & Rheumatology 58 (3): 875–887.CrossRef
16.
Zurück zum Zitat Monte, K., C. Wilson, and F.F. Shih. 2008. Increased number and function of Foxp3 regulatory T cells during experimental arthritis. Arthritis and Rheumatism 58 (12): 3730–3741.CrossRefPubMedPubMedCentral Monte, K., C. Wilson, and F.F. Shih. 2008. Increased number and function of Foxp3 regulatory T cells during experimental arthritis. Arthritis and Rheumatism 58 (12): 3730–3741.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Belkaid, Y. 2007. Regulatory T cells and infection: a dangerous necessity. Nature Reviews Immunology 7 (11): 875–888.CrossRefPubMed Belkaid, Y. 2007. Regulatory T cells and infection: a dangerous necessity. Nature Reviews Immunology 7 (11): 875–888.CrossRefPubMed
18.
Zurück zum Zitat Flores-García, Y., J.L. Rosales-Encina, V.H. Rosales-García, A.R. Satoskar, and P. Talamás-Rohana. 2013. Cd4+ cd25+ Foxp3+ Treg cells induced by rSSP4 derived from T. cruzi amastigotes increase parasitemia in an experimental Chagas disease model. BioMed Research International 2013 (1): 632436.PubMed Flores-García, Y., J.L. Rosales-Encina, V.H. Rosales-García, A.R. Satoskar, and P. Talamás-Rohana. 2013. Cd4+ cd25+ Foxp3+ Treg cells induced by rSSP4 derived from T. cruzi amastigotes increase parasitemia in an experimental Chagas disease model. BioMed Research International 2013 (1): 632436.PubMed
19.
Zurück zum Zitat Manuscript, A., G. Schett, J.M. Dayer, B. Manger, F.A. Amaral, V.V. Costa, et al. 2015. Mechanisms of inflammation in gout. Rheumatology 12 (2): 1090–1096. Manuscript, A., G. Schett, J.M. Dayer, B. Manger, F.A. Amaral, V.V. Costa, et al. 2015. Mechanisms of inflammation in gout. Rheumatology 12 (2): 1090–1096.
20.
Zurück zum Zitat Martinon, F., V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440 (7081): 237–241.CrossRefPubMed Martinon, F., V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440 (7081): 237–241.CrossRefPubMed
21.
Zurück zum Zitat Acosta-Rodriguez, E.V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nature Immunology 8 (9): 942–949.CrossRefPubMed Acosta-Rodriguez, E.V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nature Immunology 8 (9): 942–949.CrossRefPubMed
22.
Zurück zum Zitat Feldhoff, L.M., C.M. Rueda, M.E. Moreno-Fernandez, J. Sauer, C.M. Jackson, C.A. Chougnet, et al. 2017. IL-1beta induced HIF-1alpha inhibits the differentiation of human FOXP3(+) T cells. Scientific Reports 7: 465.CrossRefPubMedPubMedCentral Feldhoff, L.M., C.M. Rueda, M.E. Moreno-Fernandez, J. Sauer, C.M. Jackson, C.A. Chougnet, et al. 2017. IL-1beta induced HIF-1alpha inhibits the differentiation of human FOXP3(+) T cells. Scientific Reports 7: 465.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Kimura, A., and T. Kishimoto. 2010. IL-6: regulator of Treg/Th17 balance. European Journal of Immunology 40 (7): 1830–1835.CrossRefPubMed Kimura, A., and T. Kishimoto. 2010. IL-6: regulator of Treg/Th17 balance. European Journal of Immunology 40 (7): 1830–1835.CrossRefPubMed
24.
Zurück zum Zitat Scanu, A., F. Oliviero, R. Ramonda, P. Frallonardo, J.M. Dayer, and L. Punzi. 2012. Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor β1 in the resolution phase. Annals of the Rheumatic Diseases 71 (4): 621–624.CrossRefPubMed Scanu, A., F. Oliviero, R. Ramonda, P. Frallonardo, J.M. Dayer, and L. Punzi. 2012. Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor β1 in the resolution phase. Annals of the Rheumatic Diseases 71 (4): 621–624.CrossRefPubMed
25.
Zurück zum Zitat Jamshidian, A., V. Shaygannejad, A. Pourazar, S.H. Zarkeshesfahani, and M. Gharagozloo. 2013. Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms. Journal of Neuroimmunology 262 (1–2): 106–112.CrossRefPubMed Jamshidian, A., V. Shaygannejad, A. Pourazar, S.H. Zarkeshesfahani, and M. Gharagozloo. 2013. Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms. Journal of Neuroimmunology 262 (1–2): 106–112.CrossRefPubMed
26.
Zurück zum Zitat Tu, Z., H. Xue, W. Chen, L. Cao, and W. Zhang. 2017. Changes of treg and Th17 cells as well as cytokines in children with acute bronchitis. Experimental & Therapeutic Medicine 14 (4): 3846–3850.CrossRef Tu, Z., H. Xue, W. Chen, L. Cao, and W. Zhang. 2017. Changes of treg and Th17 cells as well as cytokines in children with acute bronchitis. Experimental & Therapeutic Medicine 14 (4): 3846–3850.CrossRef
27.
Zurück zum Zitat Abeles, A.M. 2015. Hyperuricemia, gout, and cardiovascular disease: an update. Current Rheumatology Reports 17 (3): 1–5.CrossRef Abeles, A.M. 2015. Hyperuricemia, gout, and cardiovascular disease: an update. Current Rheumatology Reports 17 (3): 1–5.CrossRef
Metadaten
Titel
Changes of Treg/Th17 Ratio in Spleen of Acute Gouty Arthritis Rat Induced by MSU Crystals
verfasst von
Xiao-Juan Dai
Jin-Hui Tao
Xuan Fang
Yuan Xia
Xiao-Mei Li
Yi-Ping Wang
Xiang-Pei Li
Publikationsdatum
23.07.2018
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 5/2018
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0839-y

Weitere Artikel der Ausgabe 5/2018

Inflammation 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.